Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today highlighted its key accomplishments in…
24 patients have been randomized 86% initial response rate to qualify for randomization Pulmonary capillary wedge pressure (PCWP) was reduced,…
The integrated drug discovery collaboration will focus on Takeda’s four core therapeutic areas WILMINGTON, Mass.–(BUSINESS WIRE)–$CRL #LIFEatCRL–Charles River (NYSE: CRL)…
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to pharmaceutical, biotechnology, medical…
— Increases KRYSTEXXA® (pegloticase injection) Peak U.S. Annual Net Sales Expectations to More Than $1 Billion — — Increases Teprotumumab…
DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance Inc. (Nasdaq: WBA) today announced that Co-Chief Operating Officer Alex Gourlay and Executive Vice President…
DUBLIN–(BUSINESS WIRE)–The “Allogeneic Stem Cells Market by Application and Geography – Forecast and Analysis 2020-2024” report has been added to…
Industry Veteran Rachel W. Humphrey, M.D., Head of R&D at TIO Discovery, appointed as Board Member and Chief Medical Officer…
Dr. Humphrey will oversee and drive clinical development efforts in TIO Bioventures’ oncology-focused portfolio companies NEW YORK–(BUSINESS WIRE)–TIO Bioventures, an…
– Topline data from Phase 3 study of omidubicel expected in first half of 2020 – – GDA-201 program progressing…